Cancer-fighting T cells do not simply "run out of energy." They are molecularly reprogrammed. For years, mitochondrial ...

The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a ...

Imaging studies of more than 27,000 adults link a healthier thymus on CT scans with a longer life and lower risks of ...

A bandage-like microneedle patch can noninvasively collect immune cells and signals from the skin within minutes to hours.

T cell activation—the process by which these key immune defenders recognize threats and mobilize against them—depends on ...

This new type of immunotherapy shows promise for treating different cancers including prostate cancer, leukaemia and lung ...

Foundational research led by co-founder Justin Eyquem, Ph.D., underpins Azalea’s proprietary in vivo CAR T platformPeer-reviewed publication ...

The role of the thymus in our long-term immunity and health is poorly understood. A new study suggests we need to pay ...

Cancer-fighting T cells do not simply "run out of energy." They are molecularly reprogrammed. For years, mitochondrial ...

Type 1 diabetes (T1D) is an autoimmune disease characterized by the immune-mediated destruction of pancreatic B cells. While autoreactive T cells are key ...

Chimeric antigen receptor T (CAR-T) cell therapy has emerged as a transformative approach in modern medicine, demonstrating ...

Researchers from Tr1x Inc. presented the development of TRX-319, a novel allogeneic regulatory T-cell therapy designed for the treatment of autoimmune disorders.